Biomarkers for ovarian cancer and endometrial cancer: hepcidin
Details for Australian Patent Application No. 2006223374 (hide)
International Classifications
Event Publications
13 September 2007 Change of Name(s) of Applicant(s), Section 104
Ciphergen Biosystems, Inc.; The Jones Hopkins University; Board Of Regnets, The University Of Texas System The name of the applicant has been changed to Ciphergen Biosystems, Inc.; The Johns Hopkins University; Board Of Regents, The University Of Texas System
20 September 2007 PCT application entered the National Phase
PCT publication WO2006/099126 Priority application(s): WO2006/099126
21 July 2011 Application Accepted
Published as AU-B-2006223374
17 November 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser